These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 14741272)

  • 1. Inhibition of alpha-chymotrypsin with thiol-bearing substrate analogues in the presence of zinc ion.
    Han MS; Oh DJ; Kim DH
    Bioorg Med Chem Lett; 2004 Feb; 14(3):701-5. PubMed ID: 14741272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-[2,2-dimethyl-3-(N-(4-cyanobenzoyl)amino)nonanoyl]-L-phenylalanine ethyl ester as a stable ester-type inhibitor of chymotrypsin-like serine proteases: structural requirements for potent inhibition of alpha-chymotrypsin.
    Iijima K; Katada J; Yasuda E; Uno I; Hayashi Y
    J Med Chem; 1999 Jan; 42(2):312-23. PubMed ID: 9925737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chymotrypsin substrate analogues inhibit endocytosis of insulin and insulin receptors in adipocytes.
    Jochen AL; Berhanu P
    J Cell Biol; 1986 Nov; 103(5):1807-16. PubMed ID: 2877995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of protease inhibitors on the basis of substrate stereospecificity.
    Kim DH
    Biopolymers; 1999; 51(1):3-8. PubMed ID: 10380348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, structure-activity relationships studies of benzoxazinone derivatives as α-chymotrypsin inhibitors.
    Marasini BP; Rahim F; Perveen S; Karim A; Mohammed Khan K; Atta-Ur-Rahman ; Choudhary MI
    Bioorg Chem; 2017 Feb; 70():210-221. PubMed ID: 28087168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction between chymotrypsin and horse leucocyte neutral proteinases inhibitor.
    Dubin A; Hauck M
    Hoppe Seylers Z Physiol Chem; 1981 Oct; 362(10):1345-9. PubMed ID: 7308999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malonyl alpha-mercaptoketones and alpha-mercaptoalcohols, a new class of matrix metalloproteinase inhibitors.
    Campbell DA; Xiao XY; Harris D; Ida S; Mortezaei R; Ngu K; Shi L; Tien D; Wang Y; Navre M; Patel DV; Sharr MA; DiJoseph JF; Killar LM; Leone CL; Levin JI; Skotnicki JS
    Bioorg Med Chem Lett; 1998 May; 8(10):1157-62. PubMed ID: 9871727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based optimisation of 2-aminobenzylstatine derivatives: potent and selective inhibitors of the chymotrypsin-like activity of the human 20S proteasome.
    Furet P; Imbach P; Fuerst P; Lang M; Noorani M; Zimmermann J; García-Echeverría C
    Bioorg Med Chem Lett; 2002 May; 12(10):1331-4. PubMed ID: 11992770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel thiol-based TACE inhibitors. Part 2: Rational design, synthesis, and SAR of thiol-containing aryl sulfones.
    Bandarage UK; Wang T; Come JH; Perola E; Wei Y; Rao BG
    Bioorg Med Chem Lett; 2008 Jan; 18(1):44-8. PubMed ID: 18054488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irreversible inhibition of serine proteases by peptide derivatives of (alpha-aminoalkyl)phosphonate diphenyl esters.
    Oleksyszyn J; Powers JC
    Biochemistry; 1991 Jan; 30(2):485-93. PubMed ID: 1988040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human alpha-1-antichymotrypsin: interaction with chymotrypsin-like proteinases.
    Travis J; Bowen J; Baugh R
    Biochemistry; 1978 Dec; 17(26):5651-6. PubMed ID: 728423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel approach to serine protease inhibition: kinetic characterization of inhibitors whose potencies and selectivities are dramatically enhanced by Zinc(II).
    Janc JW; Clark JM; Warne RL; Elrod KC; Katz BA; Moore WR
    Biochemistry; 2000 Apr; 39(16):4792-800. PubMed ID: 10769136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metal ion substitution in the catalytic site greatly affects the binding of sulfhydryl-containing compounds to leucyl aminopeptidase.
    Cappiello M; Alterio V; Amodeo P; Del Corso A; Scaloni A; Pedone C; Moschini R; De Donatis GM; De Simone G; Mura U
    Biochemistry; 2006 Mar; 45(10):3226-34. PubMed ID: 16519517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on new synthetic inhibitors of kallikreins and chymotrypsin.
    Yokoyama T; Yokoo N; Sato F; Ikegaya K; Hattori E; Watanabe K; Kirihara J; Nagakura M; Fujii S
    Adv Exp Med Biol; 1989; 247B():271-6. PubMed ID: 2610072
    [No Abstract]   [Full Text] [Related]  

  • 15. Enhancement of chymotrypsin-inhibitor/substrate interactions by 3 M NaCl.
    Wesołowska O; Krokoszyńska I; Krowarsch D; Otlewski J
    Biochim Biophys Acta; 2001 Feb; 1545(1-2):78-85. PubMed ID: 11342033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternate substrate inhibitors of an alpha-chymotrypsin: enantioselective interaction of aryl-substituted enol lactones.
    Baek DJ; Reed PE; Daniels SB; Katzenellenbogen JA
    Biochemistry; 1990 May; 29(18):4305-11. PubMed ID: 2350538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new substrate and two inhibitors applicable for thermitase, subtilisin BPN' and alpha-chymotrypsin. Comparison of kinetic parameters with customary substrates and inhibitors.
    Brömme D; Fittkau S
    Biomed Biochim Acta; 1985; 44(7-8):1089-94. PubMed ID: 3910035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substrate specificity of the chymotrypsin-like protease in secretory granules isolated from rat mast cells.
    Le Trong H; Neurath H; Woodbury RG
    Proc Natl Acad Sci U S A; 1987 Jan; 84(2):364-7. PubMed ID: 3540962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible inhibition of sheep liver sorbitol dehydrogenase by thiol compounds.
    Lindstad RI; McKinley-McKee JS
    Eur J Biochem; 1996 Oct; 241(1):142-8. PubMed ID: 8898899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metal mediated protease inhibition: design and synthesis of inhibitors of the human cytomegalovirus (hCMV) protease.
    Dhanak D; Burton G; Christmann LT; Darcy MG; Elrod KC; Kaura A; Keenan RM; Link JO; Peishoff CE; Shah DH
    Bioorg Med Chem Lett; 2000 Oct; 10(20):2279-82. PubMed ID: 11055338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.